Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Gross Margin (2018 - 2026)

Insmed's Gross Margin history spans 9 years, with the latest figure at 84.5% for Q1 2026.

  • Quarterly Gross Margin rose 742.0% to 84.5% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 81.81% through Mar 2026, up 532.0% year-over-year, with the annual reading at 79.73% for FY2025, 330.0% up from the prior year.
  • Gross Margin came in at 84.5% for Q1 2026, up from 83.24% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 84.5% in Q1 2026 to a low of 73.86% in Q2 2025.
  • The 5-year median for Gross Margin is 77.96% (2022), against an average of 78.13%.
  • Year-over-year, Gross Margin plummeted -300bps in 2024 and then surged 828bps in 2025.
  • Insmed's Gross Margin stood at 77.96% in 2022, then grew by 0bps to 77.96% in 2023, then dropped by -4bps to 74.96% in 2024, then rose by 11bps to 83.24% in 2025, then rose by 2bps to 84.5% in 2026.
  • Per Business Quant, the three most recent readings for INSM's Gross Margin are 84.5% (Q1 2026), 83.24% (Q4 2025), and 79.37% (Q3 2025).